JPH10175860A - Water (of chinese medicine idea) improver and composition for oral administration containing the same - Google Patents

Water (of chinese medicine idea) improver and composition for oral administration containing the same

Info

Publication number
JPH10175860A
JPH10175860A JP9260525A JP26052597A JPH10175860A JP H10175860 A JPH10175860 A JP H10175860A JP 9260525 A JP9260525 A JP 9260525A JP 26052597 A JP26052597 A JP 26052597A JP H10175860 A JPH10175860 A JP H10175860A
Authority
JP
Japan
Prior art keywords
action
general formula
represented
embedded image
following general
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9260525A
Other languages
Japanese (ja)
Inventor
Masanori Kosuge
正規 小菅
Takuo Kosuge
卓夫 小菅
Makoto Fukushima
信 福島
Yasunori Inaoka
靖規 稲岡
Takehiro Okuda
剛弘 奥田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DOKUTAAZU KOSUMETEIKUSU KK
Pola Chemical Industries Inc
Original Assignee
DOKUTAAZU KOSUMETEIKUSU KK
Pola Chemical Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DOKUTAAZU KOSUMETEIKUSU KK, Pola Chemical Industries Inc filed Critical DOKUTAAZU KOSUMETEIKUSU KK
Priority to JP9260525A priority Critical patent/JPH10175860A/en
Publication of JPH10175860A publication Critical patent/JPH10175860A/en
Pending legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain the subject composition capable of stimulating organs con trolling the secretion of water to the outside of the body, promoting and improv ing water (of Chinese medicine idea) action for promoting the secretion of water in the body to the outside of the body, comprising a specific compound as an active ingredient. SOLUTION: This external preparation comprises one or more selected from the group consisting of a compound of formula I (R1 to R8 are each H, a short- chain alkyloxy, OH, an acyloxy or a short chain alkyl; A is H or a carbon atom bonded to OH; B and D are each O or carbonyl), its physiologically permissible salt and its glycoside as an active ingredient. Preferably, to be concrete, quercetin of formula II, campherol of formula III, etc., are used as the compound. The content of the compound is preferably 0.001-50 wt.% based on the total of the composition in the case of a food composition.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、津液作用の改善効
果を有する津液改善剤、及びそれを含有する食品、医薬
等の経口投与用組成物に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an agent for improving tsunami which has an effect of improving the effect of tsunami, and a composition containing the same for oral administration of foods, medicines and the like.

【0002】[0002]

【従来の技術】漢方思想における気、血、水の考え方
は、その薬理作用の捉え方のユニークさと、漢方薬選択
時の合理的な指標であるために、古くより研究されてき
た。これらの内、気、血の意味するものについては、多
くのことが解明されてきた。例えば、血とは酸素、栄養
等エネルギーを中心とする補給・代謝を表すキーワード
であり、気とは生命活動の恒常性機構の活動状況と生命
活動の原動力の状況を表すキーワードであることが知ら
れている。
2. Description of the Related Art The concept of qi, blood, and water in Chinese medicine has long been studied because of its uniqueness in understanding its pharmacological action and a rational index for selecting Chinese medicine. Of these, many have been elucidated about the meanings of qi and blood. For example, it is known that blood is a keyword that represents the supply and metabolism mainly of energy such as oxygen and nutrition, and ki is a keyword that represents the status of the homeostasis of life activity and the status of the driving force of life activity. Have been.

【0003】しかし、水(津液)の働きについては老廃
物の代謝・排泄作用のみしか知られておらず、気・血・
水の論理体型において遅れて認識された為、その真の作
用(津液作用)の解明は未完であった。また、津液作用
と現代医学で認識されている種々の薬理作用等との関係
や津液の現代医学における役割などはあまり知られてお
らず、現代医学の分野における津液作用の解明及び津液
作用の改善をもたらす食品や医薬等の開発が望まれてい
た。
[0003] However, only the metabolism and excretion of waste products is known for the function of water (tsu liquor).
Since the recognition was delayed in the logical form of water, the elucidation of its true action (Tsukumi action) was incomplete. Also, little is known about the relationship between the pulp action and the various pharmacological actions recognized in modern medicine, and the role of pulp in modern medicine. The development of foods, medicines, etc. that bring about this has been desired.

【0004】[0004]

【発明が解決しようとする課題】本発明はこのような状
況を踏まえてなされたものであり、津液の真の作用を明
らかにし、津液作用を改善しうる物質及びそれを含有す
る食品、医薬等の経口投与用組成物を提供することを課
題とする。
DISCLOSURE OF THE INVENTION The present invention has been made in view of such circumstances, and clarifies the true action of tsuju, and can improve the tsuju action, and foods, medicines and the like containing the same. It is an object of the present invention to provide a composition for oral administration.

【0005】[0005]

【課題を解決するための手段】本発明者等は、このよう
な状況に鑑み、津液の真の作用を求めて鋭意研究を重ね
た結果、津液作用が、ある種の物質の働きによって水分
の体外への分泌を司る器官を刺激し、体内水分の体外へ
の分泌を促進させる作用を意味していることを見いだし
た。そして、そのような分泌器官を刺激し津液作用を促
進・改善しうる物質である津液改善剤を見出し、本発明
を完成した。
Means for Solving the Problems In view of such a situation, the present inventors have conducted intensive studies in search of the true function of tsuju. It was found that it stimulates the organs responsible for extracorporeal secretion and promotes the secretion of body water out of the body. Then, they found a tsumuco-ameliorating agent, which is a substance capable of stimulating such secretory organs and promoting / improving the action of tsumuju, and completed the present invention.

【0006】すなわち、本発明は、下記一般式(I)で
表される化合物、前記化合物の生理的に許容される塩、
又は前記化合物の配糖体からなる津液改善剤を提供する
ものである。
That is, the present invention provides a compound represented by the following general formula (I), a physiologically acceptable salt of the compound,
Another object of the present invention is to provide a tsumumo improver comprising a glycoside of the compound.

【0007】[0007]

【化13】 Embedded image

【0008】[式(I)中、R1、R2、R3、R4
5、R6、R7、及びR8はそれぞれ独立に水素原子、低
鎖長アルキルオキシ基、水酸基、アシルオキシ基又は低
鎖長アルキル基を表し、Aは水素原子が結合した炭素原
子又は水酸基が結合した炭素原子を表し、B及びDはそ
れぞれ独立に酸素原子又はカルボニル基を表す。] また、本発明は、前記津液改善剤を含有する経口投与用
組成物を提供するものである。
In the formula (I), R 1 , R 2 , R 3 , R 4 ,
R 5 , R 6 , R 7 , and R 8 each independently represent a hydrogen atom, a low-chain alkyloxy group, a hydroxyl group, an acyloxy group or a low-chain alkyl group, and A represents a carbon atom or a hydroxyl group to which a hydrogen atom is bonded. Represents a bonded carbon atom, and B and D each independently represent an oxygen atom or a carbonyl group. In addition, the present invention provides a composition for oral administration containing the above-mentioned tsuyu improving agent.

【0009】本発明の津液改善剤とは、水分の体外への
分泌を司る器官を刺激して体内水分の体外への分泌を促
し津液作用を促進・改善する作用、すなわち津液改善作
用を有する物質をいう。本発明者らは、津液作用が真皮
から表皮への水分分泌を促進し表皮に十分な水分を保持
させることによって起こる美肌作用、アトピー性皮膚
炎、湿疹、皮膚真菌症、疣贅、色素沈着症、尋常性乾
癬、老人性乾皮症、老人性角化腫、火傷等の各種皮膚疾
患治療作用、発毛促進作用、発汗促進作用、胃壁、腎
臓、腸管での水分分泌を促進させることによって起こる
消化液分泌促進作用、利尿作用、便通促進作用にかかわ
る作用であることを見出した。
[0009] The tsumuco-ameliorating agent of the present invention is a substance having an effect of stimulating an organ responsible for secretion of water to the outside of the body to promote secretion of body water to the outside of the body, thereby promoting / improving the tsukumu effect, that is, a substance having a tsumuju-improving effect. Say. The present inventors have proposed a tanning effect that promotes the secretion of water from the dermis to the epidermis and retains sufficient water in the epidermis, a beautiful skin effect, atopic dermatitis, eczema, dermatomycosis, warts, and pigmentation. It is caused by promoting the treatment of various skin diseases such as psoriasis vulgaris, senile xeroderma, senile keratoma, and burns, promoting hair growth, promoting sweating, and promoting water secretion in the stomach wall, kidneys and intestinal tract. It has been found that it is an action related to digestive juice secretion promoting action, diuretic action, and bowel movement promoting action.

【0010】すなわち、漢方生薬の薬効分類を詳細に検
討し、現代医薬分類との対比を行った結果、水(津液)
が関与すると言われている、しゃ下、利水、消導、補陰
と言った薬草群の作用が現代医薬品分類における美肌作
用、アトピー性皮膚炎治療作用、湿疹で代表される皮膚
炎群治療作用、皮膚真菌症治療作用、疣贅治療作用、肝
炎で代表される色素沈着症治療作用、尋常性乾癬治療
症、老人性乾皮症、老人性角化腫治療作用、物理的原因
による皮膚損傷治療作用、発毛促進作用、消化液分泌促
進作用、発汗促進作用、利尿作用、便通促進作用と係わ
りが深いことを見いだした。
That is, the medicinal classification of Chinese herbal medicines was examined in detail, and compared with modern medicine classifications.
It is said that the effects of the herbs such as shampoo, irrigation, conduction and prosthesis are related to beautiful skin effect, atopic dermatitis treatment, and dermatitis group treatment represented by eczema in the modern pharmaceutical classification. , Dermatomycosis treatment, wart treatment, pigmentation such as hepatitis, psoriasis vulgaris, senile xeroderma, senile keratoma treatment, skin damage treatment due to physical causes It has been found that it is closely related to the action, the hair growth promoting action, the digestive juice secretion promoting action, the sweating promoting action, the diuretic action and the bowel movement promoting action.

【0011】この知見をもとに種々の物質について美肌
作用、アトピー性皮膚炎治療作用、発毛促進作用、湿疹
の治療作用、消化液分泌促進作用、発汗促進作用を指標
にスクリーニングを重ねたところ、上記一般式(I)で
表される化合物、その生理的に許容される塩、又はその
配糖体がこのような作用に優れることを見いだした。上
記一般式(I)で表される化合物、その生理的に許容さ
れる塩又はその配糖体が経皮吸収促進作用、肝機能の改
善や免疫機能の改善作用を有していることは知られてい
るものの、真の意味での津液改善作用があることは知る
余地もなかった。更に、上記一般式(I)で表される化
合物、その生理的に許容される塩又はその配糖体が美肌
作用、アトピー性皮膚炎、湿疹、皮膚真菌症、疣贅、色
素沈着症、尋常性乾癬、老人性乾皮症、老人性角化腫、
火傷等の皮膚疾患治療作用、発毛促進作用、発汗促進作
用、消化液分泌促進作用、利尿作用、便通促進作用を有
することは全く知られていなかった。
Based on this finding, screening was carried out on various substances based on the indicators of skin beautiful action, atopic dermatitis treatment action, hair growth promotion action, eczema treatment action, digestive juice secretion promotion action and sweating promotion action. It has been found that the compound represented by the general formula (I), a physiologically acceptable salt thereof, or a glycoside thereof is excellent in such an action. It is known that the compound represented by the general formula (I), a physiologically acceptable salt thereof, or a glycoside thereof has a transdermal absorption promoting action, a liver function improving action and an immune function improving action. Despite the fact, there was no way to know that there was a true improvement of tsuyu. Furthermore, the compound represented by the above general formula (I), a physiologically acceptable salt thereof or a glycoside thereof may be used as a beautifying effect, atopic dermatitis, eczema, dermatomycosis, warts, pigmentation, vulgaris Senile psoriasis, senile xeroderma, senile keratoma,
It was not known at all that it had an action of treating skin diseases such as burns, an action of promoting hair growth, an action of promoting perspiration, an action of promoting digestive juice secretion, an action of diuresis, and an action of promoting bowel movement.

【0012】[0012]

【発明の実施の形態】以下に、本発明の実施の形態を説
明する。 (1)本発明の津液改善剤 本発明の津液改善剤は、上記一般式(I)で表される化
合物、前記化合物の生理的に許容される塩、又は前記化
合物の配糖体からなる。式(I)中、R1、R2、R3
4、R5、R6、R7、及びR8はそれぞれ独立に水素原
子、低鎖長アルキルオキシ基、水酸基、アシルオキシ基
又は低鎖長アルキル基を表し、Aは水素原子が結合した
炭素原子又は水酸基が結合した炭素原子を表し、B及び
Dはそれぞれ独立に酸素原子又はカルボニル基を表す。
ここで、低鎖長とは好ましくは炭素数1〜4の直鎖又は
分岐のアルキル基である。
Embodiments of the present invention will be described below. (1) Tsutsumi-improving agent of the present invention The tsumumo-improving agent of the present invention comprises a compound represented by the above general formula (I), a physiologically acceptable salt of the compound, or a glycoside of the compound. In the formula (I), R 1 , R 2 , R 3 ,
R 4 , R 5 , R 6 , R 7 and R 8 each independently represent a hydrogen atom, a low-chain alkyloxy group, a hydroxyl group, an acyloxy group or a low-chain alkyl group, and A represents a carbon atom to which a hydrogen atom is bonded. Represents a carbon atom to which an atom or a hydroxyl group is bonded, and B and D each independently represent an oxygen atom or a carbonyl group.
Here, the low chain length is preferably a linear or branched alkyl group having 1 to 4 carbon atoms.

【0013】一般式(I)において、本発明の津液改善
剤としては、R3とR6は水酸基であることが好ましい。
一般式(I)で表される化合物としては、クエルセチ
ン、カンフェロール、ゲンカイン、ゲニステイン、ダイ
ズエイン、バイカレイン、デオキシクエルセチン、デオ
キシカンフェロール、デオキシゲンカイン、デオキシゲ
ニステイン、デオキシダイズエイン、イソフェレイリ
ン、7−O−エチルイソフェレイリン、レスペデオール
C、イソサチバノン、ネオウラレノール、6−メトキシ
カンフェロール等が例示でき、これらがいずれも使用で
きる。
In the general formula (I), R 3 and R 6 are preferably a hydroxyl group in the rubbing improver of the present invention.
Examples of the compound represented by the general formula (I) include quercetin, campherol, gencaine, genistein, soybean, baicalein, deoxyquercetin, deoxycampherol, deoxygencaine, deoxygenistein, deoxydaizuein, isoferrein, and 7-O-. Examples include ethylisoferrein, respedeol C, isosativanone, neouralenol, and 6-methoxycampherol, all of which can be used.

【0014】これらの内好ましいものは、下記一般式
(II)で表されるクエルセチン、下記一般式(II
I)で表されるカンフェロール、下記一般式(IV)で
表されるゲンカイン、下記一般式(V)で表されるゲニ
ステイン、下記一般式(VI)で表されるダイズエイ
ン、下記一般式(VII)で表されるバイカレイン、下
記一般式(VIII)で表されるデオキシクエルセチ
ン、下記一般式(IX)で表されるデオキシカンフェロ
ール、下記一般式(X)で表されるデオキシゲンカイ
ン、下記一般式(XI)で表されるデオキシゲニステイ
ン、もしくは下記一般式(XII)で表されるデオキシ
ダイズエイン、又はこれらのアシル化物である。
Among these, quercetin represented by the following general formula (II) and quercetin represented by the following general formula (II)
Camperol represented by I), Genkain represented by the following general formula (IV), genistein represented by the following general formula (V), soybean represented by the following general formula (VI), and the following general formula (VII) ), Deoxyquercetin represented by the following general formula (VIII), deoxycampferol represented by the following general formula (IX), deoxygencaine represented by the following general formula (X), Deoxygenistein represented by the formula (XI), deoxydaidzuin represented by the following general formula (XII), or an acylated product thereof.

【0015】[0015]

【化14】 Embedded image

【0016】[0016]

【化15】 Embedded image

【0017】[0017]

【化16】 Embedded image

【0018】[0018]

【化17】 Embedded image

【0019】[0019]

【化18】 Embedded image

【0020】[0020]

【化19】 Embedded image

【0021】[0021]

【化20】 Embedded image

【0022】[0022]

【化21】 Embedded image

【0023】[0023]

【化22】 Embedded image

【0024】[0024]

【化23】 Embedded image

【0025】[0025]

【化24】 Embedded image

【0026】アシル化は通常の方法に準じて行えば良
く、例えば、アルカリ存在下、酸に塩化チオニル等を反
応させて誘導した酸塩化物や酸無水物を反応させればよ
い。前記一般式(I)で表される化合物の生理的に許容
される塩としては、例えば、ナトリウム、カリウム等の
アルカリ金属塩、カルシウム、マグネシウム等のアルカ
リ土類金属塩、アンモニウム塩、トリエチルアミンやト
リエタノールアミン等の有機アミン塩、リジンやアルギ
ニン等の塩基性アミノ酸塩等が好ましく例示できる。こ
れらの対塩基は1種でも2種以上で組み合わせて用いて
も構わない。
The acylation may be carried out according to a conventional method, for example, by reacting an acid chloride or an acid anhydride derived by reacting an acid with thionyl chloride or the like in the presence of an alkali. Examples of the physiologically acceptable salt of the compound represented by the general formula (I) include alkali metal salts such as sodium and potassium, alkaline earth metal salts such as calcium and magnesium, ammonium salts, triethylamine and triethylamine. Organic amine salts such as ethanolamine and basic amino acid salts such as lysine and arginine can be preferably exemplified. These counterbases may be used alone or in combination of two or more.

【0027】前記一般式(I)で表される化合物の配糖
体としては、α−グルコシド、β−グルコシド、α−ガ
ラクトシド、β−ガラクトシド等が例示でき、具体的に
は、ゲニステインの配糖体であるゲニスチン、ダイズエ
インの配糖体であるダイズインが好ましく例示できる。
これらは市販されているものも多く、また大豆等から抽
出したり、アグリコンと糖をガラクトシダーゼやグルコ
シダーゼ等の酵素により配糖体化することによっても得
られる。
Examples of glycosides of the compound represented by the general formula (I) include α-glucoside, β-glucoside, α-galactoside, β-galactoside, and the like. Preferred examples include genistin, which is a body, and soybean, which is a glycoside of soybean.
Many of these are commercially available, and can also be obtained by extracting from soybeans or the like, or by glycosylating aglycone and sugar with an enzyme such as galactosidase or glucosidase.

【0028】これらの一般式(I)で表される化合物、
その生理的に許容される塩、及び配糖体はいずれも市販
されており、入手可能である。本発明の上記一般式
(I)で表される化合物、前記化合物の生理的に許容さ
れる塩、又は前記化合物の配糖体からなる津液改善剤
は、津液作用を促進・改善する効果を有する。
Compounds represented by these general formulas (I):
Both physiologically acceptable salts and glycosides are commercially available and available. The compound of the present invention represented by the above general formula (I), a physiologically acceptable salt of the compound, or a tsunami improving agent composed of a glycoside of the compound has an effect of promoting and improving the tsunami action. .

【0029】津液作用は、その発現形態としてしゃ下作
用、利水作用、補陰作用、消導作用として生体に発現す
ることが知られている。これらの作用を有する漢方生薬
としては、しゃ下作用であれば、ダイオウ、バンシャヨ
ウ、ロカイ、マシニン、ケンゴシ、カンスイ、ゲンカ、
ゾクズイシ、ウキュウコンピ等が知られており、利水作
用を有する漢方生薬としては、チョレイ、ブクリョウ、
タクシャ、インチンコウ、ヨクイニン、トウカニン、ジ
フシ、トウキヒ、キンセンソウ等が知られており、補陰
作用を有する漢方生薬としては、シャジン、セイヨウジ
ン、テンモンドウ、バクモンドウ、セッコク、ギョクチ
ク、ヒャクゴウ、ソウキセイ、カンレンソウ、ジョテイ
シ、ゴマ、コクズ、キバン、ベッコウ等が知られてお
り、消導作用を有する漢方生薬としては、サンザシ、ク
レンコンピ、ヒシ、カクシツ、ライガン、ビンロウジ、
ナンカシ、タイサン等が知られている。
It is known that the tsuju action is expressed in the living body as a mode of expression, such as a subcutaneous action, a water-supply action, a prosthesis action, and a conduction action. As a herbal medicine having these effects, if it is a depressant effect, rhubarb, banshayou, rokai, machinin, kengoshi, kansui, genka,
Zokuzi-ishi, kyukyu-compi, and the like are known, and as herbal crude drugs having a water-utilizing effect, chorei, bukuro,
Taksha, chinko, yokuinin, toucanin, difushi, tokhihi, calendula, etc. are known, and as herbal crude drugs having a prominence action, shajin, seijin, tenmondou, bakkumondou, sekikoku, goktyku, zyaku, sukiyase, kanrensou, jyoseishi , Sesame, kokuzuku, kiban, bekko, etc. are known, and as a herbal medicine having an antidepressant action, hawthorn, cren compi, hishi, kakushitsu, ligan, areca,
Nankashi, Taisan and the like are known.

【0030】これらについての文献等を調べてみると、
美肌作用、発毛促進作用、抗アレルギー作用、抗炎症作
用、消化促進作用等の薬理作用が重複していることが見
出された。ここに本発明者等は注目し、「水」(津液)
の作用は現代医学における美肌作用、アトピー性皮膚
炎、湿疹、皮膚真菌症、疣贅、色素沈着症、尋常性乾
癬、老人性乾皮症、老人性角化腫、火傷等の皮膚疾患の
治療作用、発毛促進作用、吹き出物の治療作用、消化液
分泌促進作用、発汗促進作用、利尿作用、便通促進作用
等を指標とすることができることを見出した。これらの
作用の一つを有する物質は、大なり小なり他の作用も有
している場合が多い。したがって、これらの作用の一つ
を指標にするスクリーニングを行えば、他の作用の推定
を行うことができる。
Examining the literature and the like about these,
It has been found that pharmacological actions such as beautifying action, hair growth-promoting action, anti-allergic action, anti-inflammatory action, and digestion promoting action overlap. Here, the present inventors pay attention, and consider "water" (Tsu liquid).
Works in modern medicine to treat skin disorders such as skin beautification, atopic dermatitis, eczema, dermatomycosis, warts, pigmentation, psoriasis vulgaris, senile xeroderma, senile keratoma and burns It has been found that the action, the hair growth promoting action, the therapeutic action of pimples, the digestive juice secretion promoting action, the sweat promoting action, the diuretic action, the bowel movement promoting action and the like can be used as indices. Substances that have one of these actions often have greater or lesser other actions. Therefore, if screening is performed using one of these actions as an index, other actions can be estimated.

【0031】本発明の津液改善剤は、美肌作用、アトピ
ー性皮膚炎治療作用、湿疹で代表される皮膚炎群治療作
用、皮膚真菌症治療作用、疣贅治療作用、肝炎で代表さ
れる色素沈着症治療作用、尋常性乾癬治療症、老人性乾
皮症、老人性角化腫治療作用、物理的原因による皮膚損
傷治療作用、発毛促進作用、消化液分泌促進作用、発汗
促進作用、便通促進作用、及び排尿促進(利尿)作用か
らなる群から選ばれる少なくとも一つを改善する作用を
有しており、これを投与することにより、肌の衰えの防
止と改善、アトピー性皮膚炎の治療と発症・悪化の防
止、発毛の促進と抜け毛の予防、湿疹の改善と悪化の予
防、便通の促進と排尿の促進等の効果が発揮される。津
液改善剤の好ましい投与量は、疾病の種類や患者の特性
によって異なるが、成人一人一日あたり、1〜1000
0mgを1回乃至は数回に分けて経口投与すればよい。
The essence improving agent of the present invention can be used as a beautifying agent, atopic dermatitis treatment, dermatitis group represented by eczema, dermatomycosis treatment, wart treatment, and pigmentation represented by hepatitis. Therapeutic action, psoriasis vulgaris treatment, senile xeroderma, senile keratomas treatment, skin damage treatment due to physical causes, hair growth promoting action, digestive juice secretion promoting action, sweat promoting action, promotion of bowel movement It has an effect of improving at least one selected from the group consisting of an action and a urination-promoting (diuretic) action, and by administering it, prevents and ameliorates skin deterioration, and treats atopic dermatitis. Effects such as prevention of onset and deterioration, promotion of hair growth and prevention of hair loss, improvement of eczema and prevention of deterioration, promotion of bowel movement and promotion of urination are exhibited. The preferred dose of the tsukumo ameliorating agent varies depending on the type of disease and the characteristics of the patient, but is preferably 1 to 1000 per adult per day.
0 mg may be orally administered once or divided into several times.

【0032】取り分け本発明で注目すべきことは、本発
明の上記一般式(I)で表される化合物、前記化合物の
生理的に許容される塩、又は前記化合物の配糖体は、経
口投与によって肌が美しくなったり発毛が促進されたり
するなど、複数の作用を同時に備えることができる点で
ある。すなわち、好ましくは、本発明の津液改善剤は、
美肌作用、アトピー性皮膚炎治療作用、湿疹で代表され
る皮膚炎群治療作用、皮膚真菌症治療作用、疣贅治療作
用、肝炎で代表される色素沈着症治療作用、尋常性乾癬
治療症、老人性乾皮症、老人性角化腫治療作用、物理的
原因による皮膚損傷治療作用、発毛促進作用、消化液分
泌促進作用、発汗促進作用、便通促進作用、及び利尿作
用からなる群から選ばれる二以上の作用を改善する効果
を有する。経口投与でこのような作用を同時に期待しう
る物質は未だ知られていない。
It should be noted that the compound represented by the above general formula (I), the physiologically acceptable salt of the compound, or the glycoside of the compound of the present invention is orally administered. It is possible to simultaneously provide a plurality of actions such as making the skin beautiful and promoting hair growth. That is, preferably, the Tsutsumi improver of the present invention,
Beautifying skin, atopic dermatitis, dermatitis represented by eczema, dermatomycosis, wart, pigmentation represented by hepatitis, psoriasis vulgaris, elderly Selected from the group consisting of xeroderma sclerosis, senile keratoma treatment, treatment of skin damage due to physical causes, hair growth promotion, digestive secretion promotion, sweat perspiration, bowel movement promotion, and diuresis It has the effect of improving two or more actions. There is no known substance capable of simultaneously achieving such an effect by oral administration.

【0033】(2)本発明の経口投与用組成物 本発明の経口投与用組成物は、本発明の上記津液改善剤
から選ばれる1種乃至は2種以上を含有することを特徴
とする。経口投与用組成物としては、顆粒剤、散剤、錠
剤、カプセル剤、キャンディー、ガム、グミ等に加工し
た、食品組成物や医薬組成物が例示できる。好ましい本
発明の津液改善剤の含有量は、食品組成物の場合、組成
物全体に対し0.001〜50重量%であり、0.01
〜20重量%がより好ましく、0.01〜15重量%が
更に好ましい。また、医薬組成物の場合は0.1〜60
重量%が好ましく、0.5〜50重量%がより好まし
く、1〜30重量%が更に好ましい。
(2) The composition for oral administration of the present invention The composition for oral administration of the present invention is characterized by containing one or more selected from the above-mentioned tsukusu improver of the present invention. Examples of the composition for oral administration include food compositions and pharmaceutical compositions processed into granules, powders, tablets, capsules, candies, gums, gummy gums, and the like. In the case of a food composition, the preferred content of the tsukusui improver of the present invention is 0.001 to 50% by weight based on the whole composition, and
-20% by weight is more preferred, and 0.01-15% by weight is even more preferred. Further, in the case of a pharmaceutical composition, 0.1 to 60
% By weight, preferably 0.5 to 50% by weight, and more preferably 1 to 30% by weight.

【0034】本発明の組成物は、上記津液改善剤以外
に、食品組成物又は医薬組成物で通常用いられている任
意成分を含有することが出来る。このような任意成分と
しては、医薬組成物であれば、賦形剤、結合剤、被覆
剤、滑沢剤、糖衣剤、崩壊剤、増量剤、矯味矯臭剤、乳
化・可溶化・分散剤、安定剤、pH調整剤、等張剤等が
例示でき、食品組成物であれば、酸化防止剤、矯味矯臭
剤、増粘剤、乳化安定剤、防腐剤、呈味剤、甘味剤、酸
味剤等が例示できる。これらの任意成分と上記津液改善
剤を常法に従って処理することにより、本発明の組成物
を製造することができる。
The composition of the present invention may contain, in addition to the above-mentioned tsutsumi-improving agent, optional components usually used in food compositions or pharmaceutical compositions. As such an optional component, if it is a pharmaceutical composition, an excipient, a binder, a coating agent, a lubricant, a sugar coating, a disintegrant, a bulking agent, a flavoring agent, an emulsifying / solubilizing / dispersing agent, Stabilizers, pH adjusters, isotonic agents, etc. can be exemplified, and in the case of food compositions, antioxidants, flavoring agents, thickeners, emulsion stabilizers, preservatives, flavoring agents, sweeteners, sour agents Etc. can be exemplified. The composition of the present invention can be produced by treating these optional components and the above-mentioned tsukumo improver according to a conventional method.

【0035】本発明の組成物は、津液作用の改善用に用
いることができる。具体的には、美肌作用、アトピー性
皮膚炎治療作用、湿疹で代表される皮膚炎群治療作用、
皮膚真菌症治療作用、疣贅治療作用、肝炎で代表される
色素沈着症治療作用、尋常性乾癬治療症、老人性乾皮
症、老人性角化腫治療作用、物理的原因による皮膚損傷
治療作用、発毛促進作用、消化液分泌促進作用、発汗促
進作用、便通促進作用、及び利尿作用からなる群から選
ばれる作用の改善のために用いることができる。
The composition of the present invention can be used for improving the essence of a liquor. Specifically, beautiful skin action, atopic dermatitis treatment action, dermatitis group treatment action represented by eczema,
Treatment for dermatomycosis, treatment for warts, treatment for pigmentation such as hepatitis, treatment for psoriasis vulgaris, treatment for senile xeroderma, senile keratoma, treatment for skin damage due to physical causes It can be used for improving an action selected from the group consisting of a hair growth promoting action, a digestive juice secretion promoting action, a sweat promoting action, a bowel movement promoting action, and a diuretic action.

【0036】[0036]

【実施例】以下に、本発明の実施例を説明する。尚、表
中の処方の数値はすべて重量部を表す。
Embodiments of the present invention will be described below. In addition, all the numerical values of the prescription in a table represent a weight part.

【0037】[0037]

【実施例1〜5】 <配合例>表1に示す成分を用いその処方に従って錠剤
を作成した。即ち、各処方成分をグラッド造粒装置に秤
込み、50重量部の20%エタノール水溶液を噴霧しな
がら混合して、粗顆粒を作成した。粗顆粒を40℃で4
8時間送風乾燥して、打錠機で打錠して250mgの錠
剤を得た。尚、表1中の数値の単位は重量部を表す。
Examples 1 to 5 <Formulation Examples> Tablets were prepared using the components shown in Table 1 according to the formulation. That is, each prescription component was weighed in a grading granulator, and mixed by spraying 50 parts by weight of a 20% aqueous ethanol solution to prepare coarse granules. Coarse granules at 40 ° C 4
It was blow-dried for 8 hours, and was tableted with a tableting machine to obtain 250 mg tablets. The units of the numerical values in Table 1 represent parts by weight.

【0038】[0038]

【表1】 [Table 1]

【0039】[0039]

【実施例6〜10】 <配合例>表2に示す成分を用いその処方に従ってキャ
ンディーを作成した。即ち、処方成分を120℃で加熱
溶解し、冷却しながら成形してキャンディーを得た。
尚、表2中の数値の単位は重量部を表す。
Examples 6 to 10 <Formulation Examples> Candies were prepared using the components shown in Table 2 according to the formulation. That is, the prescription components were heated and melted at 120 ° C. and molded while cooling to obtain a candy.
The units of the numerical values in Table 2 represent parts by weight.

【0040】[0040]

【表2】 [Table 2]

【0041】[0041]

【実施例11〜15】 <配合例>表3に示す成分を用いその処方に従ってキャ
ンディーを作成した。即ち、処方成分を120℃で加熱
溶解し、冷却しながら成形してキャンディーを得た。
尚、表3中の数値の単位は重量部を表す。
Examples 11 to 15 <Formulation Examples> Candies were prepared using the components shown in Table 3 according to the formulation. That is, the prescription components were heated and melted at 120 ° C. and molded while cooling to obtain a candy.
The units of the numerical values in Table 3 represent parts by weight.

【0042】[0042]

【表3】 [Table 3]

【0043】[0043]

【実施例16】 <試験例1:美肌改善作用>肌荒れに悩む21〜33歳
のパネラー1群10名が、上記実施例1〜5の錠剤(1
g錠)を1日朝晩2回1錠ずつ2ヶ月間のみ、肌荒れの
改善効果を評価した。評価の基準は、非常に改善した
(評点5)〜改善しない(評点0)、とした。対照とし
ては、本発明の津液改善剤を乳糖に置換したものを用い
た。結果を平均評点として表4に示す。これより、本発
明の津液改善剤が内服によって肌荒れを改善する作用を
有すること、即ち、美肌作用を有することがわかる。
Example 16 <Test Example 1: Effect of improving skin beautifulness> Ten groups of panelists aged 21 to 33 years old suffering from rough skin,
g tablets) was evaluated twice a day in the morning and evening twice, one tablet only for two months, to evaluate the effect of improving skin roughness. The evaluation criteria were very improved (gradation 5) to not improved (gradation 0). As a control, lactose was used in place of the liquor improving agent of the present invention. The results are shown in Table 4 as average scores. From this, it can be seen that the rubbing liquid improving agent of the present invention has an effect of improving skin roughness by internal use, that is, has a beautiful skin effect.

【0044】[0044]

【表4】 [Table 4]

【0045】[0045]

【実施例17】 <試験例2:発毛促進作用>C3Hマウス1群5匹の背
部を剃毛し、下記表5に示す検体10mgを生理食塩水
200μlに溶解又は分散させて経口投与し、その後の
毛の生え方を観察して発毛促進作用を評価した。対照は
ベヒクルの生理食塩水のみとした。評価の基準は、++
(評点4):対照に比べて著しく早い、+(評点2):
対照に比べて早い、±(評点1):対照に比べてやや早
い、−(評点0):対照に比べて早くない、とした。結
果を平均評点として表5に示す。これより、本発明の津
液改善剤は発毛促進作用に優れることがわかる。
Example 17 <Test Example 2: Hair growth promoting action> The back of five C3H mice per group was shaved, and 10 mg of a sample shown in Table 5 below was dissolved or dispersed in 200 µl of physiological saline and orally administered. The subsequent hair growth was observed to evaluate the hair growth promoting action. The control was vehicle saline only. Evaluation criteria are ++
(Score 4): significantly faster than control, + (score 2):
Earlier than control, ± (score 1): slightly earlier than control,-(score 0): not earlier than control. The results are shown in Table 5 as average scores. From this, it can be seen that the tsukumo improver of the present invention is excellent in hair growth promoting action.

【0046】[0046]

【表5】 [Table 5]

【0047】[0047]

【実施例18】 <試験例3:アトピー性皮膚炎に対する作用>アトピー
性皮膚炎に悩む20〜33歳のパネラー1群10名が、
上記実施例1〜5の錠剤(1g錠)を1日朝晩2回1錠
ずつ2ヶ月間のみ、アトピー性皮膚炎の改善効果を評価
した。評価の基準は、非常に改善した(評点5)〜改善
しない(評点0)、とした。対照としては、本発明の津
液改善剤を乳糖に置換したものを用いた。結果を平均評
点として表6に示す。これより、本発明の津液改善剤が
内服によってアトピー性皮膚炎を改善する作用を有する
ことがわかる。
Example 18 <Test Example 3: Effect on Atopic Dermatitis> A group of 20 to 33-year-old panelists suffering from atopic dermatitis,
The ameliorating effects of atopic dermatitis were evaluated for the tablets (1 g tablets) of the above Examples 1 to 5 twice a day and twice a day only for two months. The evaluation criteria were very improved (gradation 5) to not improved (gradation 0). As a control, lactose was used in place of the liquor improving agent of the present invention. The results are shown in Table 6 as average scores. From this, it can be seen that the tsumugi improver of the present invention has an effect of improving atopic dermatitis by taking it internally.

【0048】[0048]

【表6】 [Table 6]

【0049】[0049]

【実施例19】 <試験例4:湿疹治療作用>吹き出物に悩む19〜29
歳のパネラー1群10名が、上記実施例1〜5の錠剤
(1g錠)を1日朝晩2回1錠ずつ2ヶ月間のみ、湿疹
の改善効果を評価した。評価の基準は、非常に改善した
(評点5)〜改善しない(評点0)、とした。対照とし
ては、本発明の津液改善剤を乳糖に置換したものを用い
た。結果を平均評点として表7に示す。これより、本発
明の津液改善剤が内服によって湿疹を改善する作用を有
することがわかる。
Example 19 <Test Example 4: Eczema treatment> 19-29 suffering from breakout
A group of 10-year-old panelists evaluated the eczema-improving effect of the tablets (1 g tablets) of Examples 1 to 5 twice a day, twice a day for two months. The evaluation criteria were very improved (gradation 5) to not improved (gradation 0). As a control, lactose was used in place of the liquor improving agent of the present invention. The results are shown in Table 7 as average scores. From this, it can be seen that the tsukutsu improver of the present invention has an effect of improving eczema by taking it internally.

【0050】[0050]

【表7】 [Table 7]

【0051】[0051]

【実施例20】 <試験例5:胃液分泌促進作用>麻酔犬を用いて胃液の
分泌促進を見た。即ち、ペントバルビツールで麻酔した
犬の胃に投与装置付き内視鏡を導入し、検体として表8
に示す本発明の津液改善剤10mgを生理食塩水10m
lに溶解又は分散させて投与し、その前後の胃液の分泌
を観察して胃液分泌促進作用を評価した。対照は生理食
塩水のみを用いた。評価の基準は、++(評点4):対
照に比べて著しく胃液分泌が増大、+(評点2):対照
に比べて胃液分泌が増大、±(評点1):対照に比べて
やや分泌が増大、−(評点0):分泌が対照に比べて増
大せず、とした。結果を表8に示す。これより、本発明
の津液改善剤は胃液分泌促進作用に優れることがわか
る。
Example 20 <Test Example 5: Gastric secretion promoting effect> The secretion of gastric juice was examined using an anesthetized dog. That is, an endoscope with an administration device was introduced into the stomach of a dog anesthetized with a pentobarbitur, and the sample was treated as shown in Table 8.
10 mg of the tsukumo improver of the present invention shown in
The solution was administered by dissolving or dispersing the solution in the gastric acid, and the secretion of gastric juice before and after the administration was observed to evaluate the gastric secretion promoting action. As a control, only physiological saline was used. Evaluation criteria were as follows: ++ (score 4): gastric secretion increased significantly compared to control, + (score 2): increased gastric secretion compared to control, ± (score 1): slightly increased compared to control ,-(Score 0): the secretion did not increase compared to the control. Table 8 shows the results. From this, it can be seen that the tsumugi improving agent of the present invention is excellent in gastric secretion promoting action.

【0052】[0052]

【表8】 [Table 8]

【0053】[0053]

【実施例21】 <試験例6:便通・排尿の促進作用>ICRマウスを代
謝ケージで飼育した。投与群は上記実施例1〜5の組成
物を1g/1日/1匹朝夕2回0.5gずつ経口投与し
た。最後の投与後24時間の尿と糞の量をモニターし
た。コントロール群は検体を投与しなかった。各サンプ
ル1群10匹とした。検体投与群の尿量の総和をコント
ロール群の尿量の総和で除した値と検体投与群の糞量の
総和をコントロール群の糞量の総和で除した値とを表9
に示す。これより本発明の一般式(I)で表される化合
物、その生理的に許容される塩、又はその配糖体は、便
通促進作用及び排尿促進作用(利尿作用)に優れること
がわかる。
Example 21 <Test Example 6: Promotion of bowel movement and urination> ICR mice were bred in metabolic cages. In the administration group, the compositions of Examples 1 to 5 were orally administered at a dose of 0.5 g twice a day in the morning and evening at 1 g / day / 1 animal. The amount of urine and feces 24 hours after the last dose was monitored. The control group received no specimen. Each group consisted of 10 animals. Table 9 shows the value obtained by dividing the total urine volume of the sample administration group by the total urine volume of the control group and the value obtained by dividing the total feces volume of the sample administration group by the total feces volume of the control group.
Shown in This shows that the compound of the present invention represented by the general formula (I), a physiologically acceptable salt thereof, or a glycoside thereof is excellent in a bowel movement promoting action and a urination promoting action (diuretic action).

【0054】[0054]

【表9】 [Table 9]

【0055】[0055]

【発明の効果】本発明によれば、美肌作用、アトピー性
皮膚炎治療作用、湿疹で代表される皮膚炎群治療作用、
皮膚真菌症治療作用、疣贅治療作用、肝炎で代表される
色素沈着症治療作用、尋常性乾癬治療症、老人性乾皮
症、老人性角化腫治療作用、物理的原因による皮膚損傷
治療作用、発毛促進作用、消化液分泌促進作用、発汗促
進作用、便通促進作用、及び利尿作用からなる群から選
ばれる津液作用を改善する効果を有する津液改善剤を提
供することができる。
According to the present invention, a beautiful skin effect, a therapeutic effect on atopic dermatitis, a therapeutic effect on a dermatitis group represented by eczema,
Treatment for dermatomycosis, treatment for warts, treatment for pigmentation such as hepatitis, treatment for psoriasis vulgaris, treatment for senile xeroderma, senile keratoma, treatment for skin damage due to physical causes The present invention can provide a tsumucolytic agent having an effect of improving a tsukusei effect selected from the group consisting of a hair growth promoting action, a digestive juice secretion promoting action, a sweating promoting action, a bowel movement promoting action, and a diuretic action.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 FI A61K 7/06 A61K 7/06 31/335 ADT 31/335 ADT 31/70 ACJ 31/70 ACJ ACQ ACQ ACX ACX // C07C 50/32 C07C 50/32 C07D 311/30 C07D 311/30 311/36 311/36 C07H 17/07 C07H 17/07 (72)発明者 福島 信 神奈川県横浜市戸塚区柏尾町560 ポーラ 化成工業株式会社戸塚研究所内 (72)発明者 稲岡 靖規 神奈川県横浜市神奈川区高島台27番地1 ポーラ化成工業株式会社横浜研究所内 (72)発明者 奥田 剛弘 神奈川県横浜市神奈川区高島台27番地1 ポーラ化成工業株式会社横浜研究所内──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. 6 Identification code FI A61K 7/06 A61K 7/06 31/335 ADT 31/335 ADT 31/70 ACJ 31/70 ACJ ACQ ACQ ACX ACX // C07C 50 / 32 C07C 50/32 C07D 311/30 C07D 311/30 311/36 311/36 C07H 17/07 C07H 17/07 (72) Inventor Shin Fukushima 560 Kashio-cho, Totsuka-ku, Yokohama-shi, Kanagawa Prefecture Pola Chemical Industry Co., Ltd. Inside the laboratory (72) Inventor Yasunori Inaoka 27-1, Takashimadai, Kanagawa-ku, Yokohama-shi, Kanagawa Pref. Inside the Yokohama Research Laboratory (72) Inventor Takehiro Okuda 27-1, Takashimadai, Kanagawa-ku, Yokohama-shi, Kanagawa Pref. Inside Yokohama Research Laboratory

Claims (7)

【特許請求の範囲】[Claims] 【請求項1】 下記一般式(I)で表される化合物、前
記化合物の生理的に許容される塩、又は前記化合物の配
糖体からなる、津液改善剤。 【化1】 [式(I)中、R1、R2、R3、R4、R5、R6、R7
及びR8はそれぞれ独立に水素原子、低鎖長アルキルオ
キシ基、水酸基、アシルオキシ基又は低鎖長アルキル基
を表し、Aは水素原子が結合した炭素原子又は水酸基が
結合した炭素原子を表し、B及びDはそれぞれ独立に酸
素原子又はカルボニル基を表す。]
1. An agent for improving essence comprising a compound represented by the following general formula (I), a physiologically acceptable salt of the compound, or a glycoside of the compound. Embedded image [In the formula (I), R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 ,
And R 8 each independently represent a hydrogen atom, a low-chain alkyloxy group, a hydroxyl group, an acyloxy group or a low-chain alkyl group; A represents a carbon atom to which a hydrogen atom is bonded or a carbon atom to which a hydroxyl group is bonded; And D each independently represent an oxygen atom or a carbonyl group. ]
【請求項2】 前記一般式(I)で表される化合物が、
下記一般式(II)で表されるクエルセチン、下記一般
式(III)で表されるカンフェロール、下記一般式
(IV)で表されるゲンカイン、下記一般式(V)で表
されるゲニステイン、下記一般式(VI)で表されるダ
イズエイン、下記一般式(VII)で表されるバイカレ
イン、下記一般式(VIII)で表されるデオキシクエ
ルセチン、下記一般式(IX)で表されるデオキシカン
フェロール、下記一般式(X)で表されるデオキシゲン
カイン、下記一般式(XI)で表されるデオキシゲニス
テイン、もしくは下記一般式(XII)で表されるデオ
キシダイズエイン又はこれらのアシル化物である、請求
項1記載の津液改善剤。 【化2】 【化3】 【化4】 【化5】 【化6】 【化7】 【化8】 【化9】 【化10】 【化11】 【化12】
2. The compound represented by the general formula (I)
Quercetin represented by the following general formula (II), campherol represented by the following general formula (III), genkine represented by the following general formula (IV), genistein represented by the following general formula (V), Soy ain represented by the general formula (VI), baicalein represented by the following general formula (VII), deoxyquercetin represented by the following general formula (VIII), deoxycampferol represented by the following general formula (IX), A deoxygencaine represented by the following general formula (X), a deoxygenistein represented by the following general formula (XI), a deoxydaidzuin represented by the following general formula (XII), or an acylated product thereof. Item 4. The tsumumo improver according to Item 1. Embedded image Embedded image Embedded image Embedded image Embedded image Embedded image Embedded image Embedded image Embedded image Embedded image Embedded image
【請求項3】 請求項1又は2記載の津液改善剤を含有
する、経口投与用組成物。
3. A composition for oral administration, comprising the tsukumo ameliorating agent according to claim 1 or 2.
【請求項4】 食品組成物である、請求項3記載の組成
物。
4. The composition according to claim 3, which is a food composition.
【請求項5】 医薬組成物である、請求項3記載の組成
物。
5. The composition according to claim 3, which is a pharmaceutical composition.
【請求項6】 津液作用の改善に用いられる、請求項3
〜5のいずれかに記載の組成物。
6. The method according to claim 3, which is used for improving a tsufluid action.
The composition according to any one of claims 1 to 5.
【請求項7】 前記津液作用が、美肌作用、アトピー性
皮膚炎治療作用、皮膚炎群治療作用、皮膚真菌症治療作
用、疣贅治療作用、色素沈着症治療作用、尋常性乾癬治
療症、老人性乾皮症、老人性角化腫治療作用、皮膚損傷
治療作用、発毛促進作用、消化液分泌促進作用、発汗促
進作用、便通促進作用、及び利尿作用からなる群から選
ばれる作用である、請求項6記載の組成物。
7. The tanning solution is effective for beautifying skin, treating atopic dermatitis, treating dermatitis, treating dermatomycosis, treating warts, treating pigmentation, treating psoriasis vulgaris, and the elderly. Xeroderma sclerosis, senile keratoma treatment action, skin damage treatment action, hair growth promotion action, digestive secretion promotion action, perspiration promotion action, bowel movement promotion action, and an action selected from the group consisting of diuretic action, A composition according to claim 6.
JP9260525A 1996-10-15 1997-09-25 Water (of chinese medicine idea) improver and composition for oral administration containing the same Pending JPH10175860A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9260525A JPH10175860A (en) 1996-10-15 1997-09-25 Water (of chinese medicine idea) improver and composition for oral administration containing the same

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8-272722 1996-10-15
JP27272296 1996-10-15
JP9260525A JPH10175860A (en) 1996-10-15 1997-09-25 Water (of chinese medicine idea) improver and composition for oral administration containing the same

Publications (1)

Publication Number Publication Date
JPH10175860A true JPH10175860A (en) 1998-06-30

Family

ID=26544642

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9260525A Pending JPH10175860A (en) 1996-10-15 1997-09-25 Water (of chinese medicine idea) improver and composition for oral administration containing the same

Country Status (1)

Country Link
JP (1) JPH10175860A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6093411A (en) * 1998-03-16 2000-07-25 The Procter & Gamble Company Compositions for regulating skin appearance
JP2004210743A (en) * 2003-01-08 2004-07-29 Nagase & Co Ltd Agent for promoting production of ceramide
JP2012193200A (en) * 2001-10-31 2012-10-11 Daicho Kikaku:Kk Dermatologic preparation

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6093411A (en) * 1998-03-16 2000-07-25 The Procter & Gamble Company Compositions for regulating skin appearance
JP2012193200A (en) * 2001-10-31 2012-10-11 Daicho Kikaku:Kk Dermatologic preparation
JP2014208697A (en) * 2001-10-31 2014-11-06 有限会社大長企画 Agent for the skin of animals
JP2004210743A (en) * 2003-01-08 2004-07-29 Nagase & Co Ltd Agent for promoting production of ceramide

Similar Documents

Publication Publication Date Title
JPH10114649A (en) Improver for aqueous body fluid and composition for oral administration comprising the same
US10383843B2 (en) Use of total coumarins of cnidium fruit in preparing medicaments for treating psoriasis
DE3040246A1 (en) SAPONINE, METHOD FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
WO1992010178A1 (en) Antipruritic drug and antipruritic composition
AT506095A1 (en) USE OF PROTEASES
CN1164297C (en) Method for preventing and curing diseases by using kakonein preparation
JP2003518066A (en) Compositions containing oligosaccharides, especially cosmetic or dermatological compositions, methods for their preparation and methods for cosmetic treatment
JPH10175859A (en) External preparation for skin for improving water (of chinese medicine idea)
JPH10120579A (en) Skin preparation for improving sputum for external use
JPH10114665A (en) Improver for aqueous body fluid and composition for oral administration comprising the same
JPH10175854A (en) External preparation for skin for improving water (of chinese medicine idea)
JPH10120558A (en) Skin preparation for improving sputum for external use
JP4049406B2 (en) Tsu fluid improving agent and composition for oral administration containing the same
JPH10175860A (en) Water (of chinese medicine idea) improver and composition for oral administration containing the same
JP4018764B2 (en) Skin preparation for improving tsunami
JPH10175852A (en) Water (of chinese medicine idea) improver and composition for oral administration containing the same
JPH10218784A (en) Medicine for external use for treating allergic dermatitis
JPH10114652A (en) Improver for aqueous body fluid and composition for oral administration comprising the same
KR101511364B1 (en) Herbal Extract Composition for Prevention or Treatment of Obesity and Metabolic Syndrome Using Herbal Extract
JPH10120561A (en) Skin preparation for improving sputum for external use
KR100486961B1 (en) The health-supporting food being effective the sexual energy strength and its preparat ion method
CN106265248A (en) Radix Notoginseng extracts the technique of coenzyme Q10 and the method preparing tooth protection skin-protection product
DE2759108A1 (en) USE OF ALPHA -MERCAPTO-BETA-ARYL-ACRYLIC ACIDS IN INCREASING THE ZINC CONTENT IN SERUM AND TISSUE
CN107890116B (en) Leucine derivatives, compositions comprising the same and uses thereof
Sutherland THE SYDNEY FUNNEL–WEB SPIDER (ATRAX ROBUSTUS): 1: A REVIEW OF PUBLISHED STUDIES ON THE CRUDE VENOM

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20071115

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20071218

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080415